Raleigh Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Sell |
4,311
-608
| -12% | -$65.3K | 0.19% | 127 |
|
|
2025
Q1 | $496K | Sell |
4,919
-890
| -15% | -$89.8K | 0.22% | 121 |
|
|
2024
Q4 | $519K | Buy |
5,809
+449
| +8% | +$40.1K | 0.2% | 120 |
|
|
2024
Q3 | $449K | Buy |
5,360
+560
| +12% | +$46.9K | 0.17% | 132 |
|
|
2024
Q2 | $370K | Buy |
4,800
+368
| +8% | +$28.3K | 0.16% | 141 |
|
|
2024
Q1 | $304K | Buy |
4,432
+953
| +27% | +$65.3K | 0.13% | 173 |
|
|
2023
Q4 | $201K | Buy |
3,479
+318
| +10% | +$18.4K | 0.09% | 186 |
|
|
2023
Q3 | $167K | Buy |
3,161
+114
| +4% | +$6.02K | 0.09% | 182 |
|
|
2023
Q2 | $165K | Buy |
3,047
+343
| +13% | +$18.6K | 0.08% | 194 |
|
|
2023
Q1 | $135K | Buy |
+2,704
| New | +$135K | 0.07% | 205 |
|